Evidence map›Paper›PMID 29445750›Full record

ArticleJournal of diabetes research2017

The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes.

Reina Kawarabayashi, Koka Motoyama, Miyuki Nakamura, Yuko Yamazaki, Tomoaki Morioka, Katsuhito Mori, Shinya Fukumoto, Yasuo Imanishi, Atsushi Shioi, Tetsuo Shoji and 2 more

Registry-linked trialOpen access · goldAbstract readComparative Study
In one paragraph

Article in Journal of diabetes research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04604041 (Investigation of Subclinical Markers of Multiple Sclerosis), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04604041 recruitingnot on this mapstarted 2020, after this paper: background citation

Investigation of Subclinical Markers of Multiple Sclerosis

TypeobservationalSponsorUniversity of Split, School of MedicineRan2020 to 2028Enrolled50ConditionsMultiple Sclerosis, Relapsing Remitting Multiple SclerosisArms1. Clinical testing, 2. Neurophysiological examination (TMS, EMNG), 3. Psychomotor examination, 4. Neuropsychological evaluation, 5. Flow cytometry
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Interleukin-10 attenuates renal injury after myocardial infarction in diabetes.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Targeting of CD163International journal of molecular sciences · 2020
    Review
  11. Article
  12. Salt-sensitive increase in macrophages in the kidneys of Dahl SS rats.American journal of physiology. Renal physiology · 2019
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Reina KawarabayashiMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Koka MotoyamaMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-8737-5774
Miyuki NakamuraMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Yuko YamazakiMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tomoaki MoriokaMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-2329-8191
Katsuhito MoriMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Shinya FukumotoDepartment of Premier Preventive Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-0099-1161
Yasuo ImanishiMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Atsushi ShioiDepartment of Vascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tetsuo ShojiDepartment of Vascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Masanori EmotoMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Masaaki InabaMetabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Osaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the association between monocyte CD163 and insulin resistance in patients with type 2 diabetes.

methodsOne hundred sixty-six patients with type 2 diabetes without inflammatory or chronic kidney disease were recruited. The monocyte CD163 levels were measured by flow cytometry and soluble CD163 (sCD163) by ELISA. Insulin resistance was evaluated by the index of the homeostasis model assessment (HOMA-R).

resultsThe median sCD163 and monocyte CD163 expression levels were 582.9 (472.4-720.0) ng/ml and 6061 (4486-7876) mean fluorescent intensity (MFI), respectively. In a simple regression analysis, monocyte CD163 was inversely correlated with log [HOMA-R] (

conclusionsMonocyte surface CD163 expression levels were more significantly associated with insulin resistance than sCD163 in patients with type 2 diabetes, suggesting a novel pathophysiological role of CD163.

Indexed as

Insulin ResistanceAgedAntigens, CDAntigens, Differentiation, MyelomonocyticBiomarkersCD163 AntigenCross-Sectional StudiesDiabetes Mellitus, Type 2Diet, DiabeticDrug Therapy, CombinationEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryHumansHypoglycemic AgentsJapanAntigens, CDAntigens, Differentiation, MyelomonocyticBiomarkersCD163 AntigenHypoglycemic AgentsReceptors, Cell Surface

Identifiers

PMID29445750
PMCPMC5763167
OpenAlexW2779757435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.